InsiderTrades

Form 4 for SOLV Solventum

Accepted 2024-12-03 00:00:00 ET · period of report 2024-12-01 · accession 0001964738-24-000063 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-12-03 2024-12-01 SOLV McMillan Wayde D. CFO F - Tax $71.51 -11.1K 16.9K -40% -$794.6K
D 2024-12-03 2024-12-01 SOLV McMillan Wayde D. CFO M - OptEx $0.00 +28.0K 28.0K +560,200% $0
D 2024-12-03 2024-12-01 SOLV McMillan Wayde D. CFO M - OptEx $0.00 -28.0K 28.0K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-12-01 F D 11,112 $71.51 16,903 D — —
2 Common Common Stock 2024-12-01 M A 28,010 $0.00 28,015 D — — (F2) Includes 5 shares held by the Reporting Person after conversion of 22 shares of 3M common stock he held prior to the spin-off from 3M that were converted to issuer's shares of stock at a ratio of one share of issuer's stock for every four shares of 3M stock, as described in the issuer's Information Statement filed with the SEC on February 20, 2024.
3 Derivative Restricted Stock Units 2024-12-01 M D 28,010 $0.00 28,010 D — · — to 2034-12-01 28,010 Common Stock (F3) Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. (F4) The RSUs shall fully vest in two tranches, with one-half vesting on each of the first and second anniversaries of the grant date, subject to continued service through the vesting date.